Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator
- 1 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 42 (11), 3110-3115
- https://doi.org/10.1161/strokeaha.111.613208
Abstract
Background and Purpose— Mild or rapidly improving stroke is a frequently cited reason for not giving intravenous recombinant tissue-type plasminogen activator (rtPA), but some of these patients may have poor outcomes. We used data from a large nationwide study (Get With The Guidelines–Stroke) to determine risk factors for poor outcomes after mild or improving stroke at hospital discharge. Methods— Between 2003 and 2009, there were 29 200 ischemic stroke patients (from 1092 hospitals) arriving within 2 hours after symptom onset with mild or rapidly improving stroke symptoms as the only contraindication to rtPA. Logistic regression was used to determine the independent predictors of discharge to home. Results— Among 93 517 patients arriving within 2 hours, 31.2% (29 200) did not receive rtPA solely because of mild/improving stroke. Among the 29 200 mild/improving cases, 28.3% were not discharged to home, and 28.5% were unable to ambulate without assistance at hospital discharge. The likelihood of home discharge was strongly related to initial National Institutes of Health Stroke Scale score (P<0.001). In multivariable-adjusted analysis, patients not discharged to home were more likely to be older, female, and black; have a higher National Institutes of Health Stroke Scale score and vascular risk factors; and were less likely to be taking lipid-lowering medication before admission. Conclusions— In this large, nationwide study, a sizeable minority of patients who did not receive intravenous rtPA solely because of mild/improving stroke had poor short-term outcomes, raising the possibility that stroke-related disability is relatively common, even in “mild” stroke. A controlled trial of reperfusion therapy in this population may be warranted.Keywords
This publication has 13 references indexed in Scilit:
- Definition and Evaluation of Transient Ischemic AttackStroke, 2009
- Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic AttackCirculation, 2009
- Hospital Treatment of Patients With Ischemic Stroke or Transient Ischemic Attack Using the “Get With The Guidelines” ProgramArchives of Internal Medicine, 2008
- Outcome of Stroke With Mild or Rapidly Improving SymptomsStroke, 2007
- Early MRI and outcomes of untreated patients with mild or improving ischemic strokeNeurology, 2006
- Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic StrokeStroke, 2005
- Recombinant Tissue Plasminogen Activator for Minor Strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study ExperienceAnnals of Emergency Medicine, 2005
- Prioritizing interventions to improve rates of thrombolysis for ischemic strokeNeurology, 2005
- Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic StrokeStroke, 2004
- Why are stroke patients excluded from TPA therapy?Neurology, 2001